These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14691746)

  • 41. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
    Dimitriadi M; Hart AC
    Neurobiol Dis; 2010 Oct; 40(1):4-11. PubMed ID: 20493260
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The worm in us - Caenorhabditis elegans as a model of human disease.
    Baumeister R; Ge L
    Trends Biotechnol; 2002 Apr; 20(4):147-8. PubMed ID: 11906745
    [No Abstract]   [Full Text] [Related]  

  • 43. Cross-species modeling of muscular dystrophy in Caenorhabditis elegans using patient-derived extracellular vesicles.
    Shalash R; Levi-Ferber M; Cohen C; Dori A; Brodie C; Henis-Korenblit S
    Dis Model Mech; 2024 Mar; 17(3):. PubMed ID: 38501170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic kidney diseases: Caenorhabditis elegans as model system.
    Ganner A; Neumann-Haefelin E
    Cell Tissue Res; 2017 Jul; 369(1):105-118. PubMed ID: 28484847
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Caenorhabditis elegans as a model system for human diseases.
    Markaki M; Tavernarakis N
    Curr Opin Biotechnol; 2020 Jun; 63():118-125. PubMed ID: 31951916
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Worms on the spectrum - C. elegans models in autism research.
    Schmeisser K; Parker JA
    Exp Neurol; 2018 Jan; 299(Pt A):199-206. PubMed ID: 28434869
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A living model for obesity and aging research: Caenorhabditis elegans.
    Shen P; Yue Y; Park Y
    Crit Rev Food Sci Nutr; 2018 Mar; 58(5):741-754. PubMed ID: 27575804
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Medical significance of Caenorhabditis elegans.
    Aboobaker AA; Blaxter ML
    Ann Med; 2000 Feb; 32(1):23-30. PubMed ID: 10711574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caenorhabditis elegans as a model system for triplet repeat diseases.
    Voisine C; Hart AC
    Methods Mol Biol; 2004; 277():141-60. PubMed ID: 15201454
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C. elegans as a model system to accelerate discovery for Parkinson disease.
    Martinez BA; Caldwell KA; Caldwell GA
    Curr Opin Genet Dev; 2017 Jun; 44():102-109. PubMed ID: 28242493
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Transparent window into biology: A primer on Caenorhabditis elegans.
    Corsi AK; Wightman B; Chalfie M
    WormBook; 2015 Jun; ():1-31. PubMed ID: 26087236
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Caenorhabditis elegans].
    Labouesse M
    Med Sci (Paris); 2003 Dec; 19(12):1171-2. PubMed ID: 14691734
    [No Abstract]   [Full Text] [Related]  

  • 53. C. elegans as a model organism for human mitochondrial associated disorders.
    Maglioni S; Ventura N
    Mitochondrion; 2016 Sep; 30():117-25. PubMed ID: 26906059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. What Can We Learn About Human Disease from the Nematode C. elegans?
    Apfeld J; Alper S
    Methods Mol Biol; 2018; 1706():53-75. PubMed ID: 29423793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automated high-content phenotyping from the first larval stage till the onset of adulthood of the nematode Caenorhabditis elegans.
    Atakan HB; Cornaglia M; Mouchiroud L; Auwerx J; Gijs MAM
    Lab Chip; 2018 Dec; 19(1):120-135. PubMed ID: 30484462
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic screens in Caenorhabditis elegans models for neurodegenerative diseases.
    Sin O; Michels H; Nollen EA
    Biochim Biophys Acta; 2014 Oct; 1842(10):1951-1959. PubMed ID: 24525026
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caenorhabditis elegans as an emerging model for studying the basic biology of obesity.
    Jones KT; Ashrafi K
    Dis Model Mech; 2009; 2(5-6):224-9. PubMed ID: 19407330
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Digging deeper: methodologies for high-content phenotyping in Caenorhabditis elegans.
    Patel DS; Xu N; Lu H
    Lab Anim (NY); 2019 Jul; 48(7):207-216. PubMed ID: 31217565
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium-dependent and aspartyl proteases in neurodegeneration and ageing in C. elegans.
    Samara C; Tavernarakis N
    Ageing Res Rev; 2003 Oct; 2(4):451-71. PubMed ID: 14522246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caenorhabditis elegans for rare disease modeling and drug discovery: strategies and strengths.
    Kropp PA; Bauer R; Zafra I; Graham C; Golden A
    Dis Model Mech; 2021 Aug; 14(8):. PubMed ID: 34370008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.